Following a Mediterranean diet long-term may have weight loss benefits but it may not be enough to enhance cognitive function ...

Memory loss might have met its match. A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could lower your risk of developing ...

WEIGHT loss jabs may also help ward off dementia, a new study suggests. Researchers found that semaglutide - the active ingredient in Ozempic and Wegovy - could "significantly" slash the risk of ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.

Weight loss jabs could prevent dementia, study finds A new study has revealed that people on these weight loss drugs had a significantly lower risk of developing dementia, especially among women.

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss drug, may lower the risk of dementia in people with type 2 diabetes (T2D).

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...